IFNA2 and hepatocellular carcinoma: The expressions of certain genes such as hepatic IFIT3, microRNA-26, or retinoic acid–inducible gene I can help predict responses of patients to adjuvant IFN-α therapy, highlighting the effectiveness of IFN-α therapy in a subgroup of patients with HCC who responded favorably.